Business Wire

CA-VELODYNE-LIDAR,-INC.

3.9.2021 06:02:10 CEST | Business Wire | Press release

Share
Velodyne Showcases Advanced Lidar and Software Solutions for Intelligent Transportation Systems and Mobile Applications at IAA Mobility

Velodyne Lidar, Inc. (Nasdaq: VLDR, VLDRW) will demonstrate its innovative lidar technologies at IAA Mobility (Hall B3, Booth A75) from Sept. 7 to 12 in Munich. Velodyne will display its technology leadership and product breadth in lidar sensors and software. Velodyne’s solutions power autonomous applications that advance safe, sustainable and accessible mobility, infrastructure and security.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210902005892/en/

Velodyne is hosting a press event at its IAA Mobility booth on Sept. 6 at 1:15 to 1:30 p.m. Velodyne executives will highlight how Velodyne´s solutions deliver the performance, range and reliability to power customers’ next-generation infrastructure and mobile applications. They will also discuss Velodyne’s portfolio of compact, solid-state sensors, which are embeddable for sleek, stylish integration into vehicles and robotics applications.

“At IAA Mobility, we will show how Velodyne’s sensors and software meet a wide range of customer needs to power safe mobility and smart city infrastructure globally,” said Erich Smidt, Vice President of Europe, Velodyne Lidar. “We will also have partners in our stand that are at the forefront in bringing to market the future of autonomous solutions. NI and Seoul Robotics are both recognized leaders in delivering high-quality solutions with the goal of improving people’s lives and increasing safety in our communities.”

Partners Showcase Lidar-Based Solutions

NI , developer of automated test and automated measurement systems, will co-exhibit at the Velodyne booth. NI will show simulations optimized for Velodyne’s lidar sensors that can be used in developing and testing advanced driver assistance systems (ADAS) and autonomous vehicle (AV) capabilities. NI simulation solutions make it easier to integrate Velodyne’s sensors into vehicle solutions, providing faster time to market and improving vehicle safety. NI will demonstrate how its monoDrive AV simulation software is using Velodyne’s lidar technology to create digital twins and is providing validated physics-based sensor models for Velodyne lidar sensors.

“Our ADAS and lidar simulation capabilities support faster system development and deployment of ADAS and AV solutions that use Velodyne’s sensors. The NI monoDrive Real-to-Virtual technology provides an end-to-end solution for collecting real-world data from cameras, lidars and GNSS systems to create high-fidelity digital twins that help to accelerate ADAS and AV development,” said Jeff Phillips, Director of Marketing for NI’s Transportation Business Unit. “The combination of Velodyne’s high-performance sensors and our simulation and validation capabilities allows developers to test and validate solutions in a massively scalable variety of conditions before they reach the road.”

Seoul Robotics , an Automated with Velodyne partner, will demonstrate at the Velodyne booth its AI perception engine for Velodyne’s lidar sensors which provides real-time object detection, classification, tracking and prediction for autonomous systems. The AI engine can power self-driving cars as well as smart city applications and advanced parameter monitoring systems for facilities. Seoul Robotics’ SENSR™ perception software includes an AI engine that is fully optimized to utilize Velodyne’s portfolio of lidar sensors, including the Puck™ , Ultra Puck™ and Alpha Prime™ .

Velodyne Highlights High Performance Sensors and Software

Among the Velodyne products showcased at IAA Mobility are:

Velarray H800 , a solid-state lidar sensor architected for automotive grade performance and built using Velodyne’s breakthrough proprietary micro-lidar array architecture (MLA). With combined long-range perception and a broad field of view, the sensor is designed for safe navigation and collision avoidance in ADAS and autonomous mobility applications. It can enable advanced driver assistance features such as Adaptive Cruise Control (ACC), Lane Keep Assist (LKA) and Pedestrian Automatic Emergency Braking (PAEB). The Velarray H800’s compact, embeddable form factor is designed to fit neatly behind the windshield of a truck, bus or car, or be mounted seamlessly on the vehicle exterior.

Velarray M1600 , an innovative solid-state lidar sensor designed to serve mobile robotic applications. The sensor is built using Velodyne’s MLA and provides outstanding near-field perception for safe navigation. The Velarray M1600 enables touchless mobile and last-mile delivery robots to operate autonomously and safely, without human intervention. This durable and compact sensor can be deployed in a wide variety of environments and weather conditions allowing nearly 365-day, 24/7 usage.

Velabit™ , Velodyne’s smallest sensor, which brings new levels of versatility and affordability to 3D lidar perception. This compact, mid-range lidar sensor is highly configurable for specialized use cases and can be embedded almost anywhere within vehicles, robots, unmanned aerial vehicles (UAVs) and infrastructure. The solid-state Velabit advances Velodyne’s mission to make high-quality 3D lidar sensors readily accessible to everyone.

Vella™ , Velodyne’s breakthrough ADAS software based on the directional view Velarray sensor. Vastly superior to existing approaches that utilize camera+radar, Vella will revolutionize advanced driver assistance functionalities currently on the market, including ACC, LKA and PAEB. The Vella Development Kit (VDK) enables companies to utilize the advanced capabilities of Vella software in their autonomous solutions. VDK helps companies use their development resources more efficiently by reducing the time and effort required to integrate 3D lidar sensors into applications.

About Velodyne Lidar

Velodyne Lidar (Nasdaq: VLDR, VLDRW) ushered in a new era of autonomous technology with the invention of real-time surround view lidar sensors. Velodyne, the global leader in lidar, is known for its broad portfolio of breakthrough lidar technologies. Velodyne’s revolutionary sensor and software solutions provide flexibility, quality and performance to meet the needs of a wide range of industries, including autonomous vehicles, advanced driver assistance systems (ADAS), robotics, unmanned aerial vehicles (UAV), smart cities and security. Through continuous innovation, Velodyne strives to transform lives and communities by advancing safer mobility for all. For more information, visit www.velodynelidar.com .

Forward Looking Statements

This press release contains “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 including, without limitation, all statements other than historical fact and include, without limitation, statements regarding Velodyne’s target markets, new products, development efforts, and competition. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “can,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Velodyne’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include uncertainties regarding government regulation and adoption of lidar, the uncertain impact of the COVID-19 pandemic on Velodyne’s and its customers’ businesses; Velodyne’s ability to manage growth; Velodyne’s ability to execute its business plan; uncertainties related to the ability of Velodyne’s customers to commercialize their products and the ultimate market acceptance of these products; the rate and degree of market acceptance of Velodyne’s products; the success of other competing lidar and sensor-related products and services that exist or may become available; uncertainties related to Velodyne’s current litigation and potential litigation involving Velodyne or the validity or enforceability of Velodyne’s intellectual property; and general economic and market conditions impacting demand for Velodyne’s products and services. For more information about risks and uncertainties associated with Velodyne’s business, please refer to the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” sections of Velodyne’s SEC filings, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. All forward-looking statements in this press release are based on information available to Velodyne as of the date hereof, Velodyne undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Link:

ClickThru

Social Media:

https://www.facebook.com/VelodyneLidar/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Doubtless Pet Care Launches to Provide Peace of Mind to Pet Parents and Help Their Pets Live Happier, Healthier Lives29.6.2026 10:15:00 CEST | Press release

Doubtless combines industry-leading pet insurance with innovative care solutions, protecting more than 6 million pets across 10 global markets Doubtless launches today with the goal of helping more pet parents across the world access quality care for the pets they love. The company brings together a leading global portfolio of pet insurance brands with a growing range of connected solutions designed to support pet parents at every stage of their pet’s life. With over 4,000 employees, Doubtless insures 6 million pets across 10 markets in North America, Europe and the United Kingdom. “Uncertainty about the financial commitments associated with having a pet should never keep families from experiencing the joy of a life with pets,” said Dirk Beeckman, CEO of Doubtless. “By harnessing the power of our international footprint, we are building on our leadership in pet insurance to create a global suite of solutions for pet parents, veterinarians and industry partners that makes pet care easie

Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)29.6.2026 09:19:00 CEST | Press release

Phase 1 study demonstrated pharmacokinetic (PK) equivalence between SB27 and Keytruda; Phase 3 study demonstrated equivalent objective response rate (ORR) at Week 24Phase 1 and Phase 3 studies expected to be completed within 2026 Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Division at Samsung Bioepis. “We are on track to complete both Phase 1 and Phase 3 studies within this year. Leveraging our robust quality management system, we remain committed to advancing our biosimilar portfolio to broaden access to life-saving biologic medicines for patie

IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment29.6.2026 09:00:00 CEST | Press release

IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/ IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Quantum: full-stack, open-architecture superconducting systems deployed on premises, inside customers' own data centers and HPC environments, where organizations own the hardware, build internal expertise, and run quantum processors alongside their existing classical infrastructure. According to the IDC MarketScape, "For institutions building long-term quantum programs, this means the workflows and intellectual property developed on IQM hardware remain portable." The report further advises: "Consi

Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations29.6.2026 09:00:00 CEST | Press release

Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa More than one million people are living with Parkinson’s disease in the European Union, and over 80% experience motor fluctuations during the course of their disease, highlighting the need for additional treatment options Hopledo® contains a unique formulation combining immediate-release granules and extended-release pellets, providing both a rapid onset of action and a longer duration of effect, sustaining the levodopa therapeutic effect for a longer period of time If approved, Zambon expects to make Hopledo® progressively available to patients with Parkinson’s disease across Europe starting October 2026 Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European M

Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors29.6.2026 08:30:00 CEST | Press release

Approval based on three phase 2 trials of Daiichi Sankyo and AstraZeneca’s Enhertu that demonstrated clinically meaningful responses across a broad range of tumors Enhertu now approved for six indications in the EU Enhertu® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from subgroups of patients with HER2 positive (IHC 3+) tumors across thr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye